EyeGene Inc.

₩1,720As of Sun 8 Nov 2026, 12:00 UTC
KOSDAQ:185490Healthcare
Country South Korea
PE (Fwd) •••
TSR 10Y CAGR (13.32%)
Div yield —
ROE (43.53%)
Biological Products, Except Diagnostic Substances
Beta (5Y) 0.68
PE TTM —
TSR TTM (7.08%)
Mkt cap ₩74.36B
ROIC (15.63%)
SE Grade™
Value
Quality
Moat
Consensus
Reference
₩1,956
13.73%
(90.26%)
Hold 6|11|4|1|11
4Q25
1Q26
2Q26
3Q26
Earnings per share₩
48.88
51.71
53.86
52.08
39.59%
37.12%
33.71%
16.33%
Revenue₩B
4.515
4.664
4.818
4.994
7.01%
9.77%
11.53%
16.09%
Peers (US$54.82M)
Cap (US$)
PE
54.82M
11.40x
45.74M
8.277x
Capital
TTM
5Y
10Y
Leveragex
5.157
0.856
0.597
EBIT/Intx
10.73
0.064
0.088
Own earn%
192.87
14.05
13.89
Sh yield%
38.95
42.23
43.49
Owners
Insiders/Inst%
8.18
76.76
Short interest%
5.59
SBC / revenue%
4.20
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
18
Op margin range%
9–17
$1 testx
—
Incr. ROIC%
1